1. Home
  2. Healthcare
  3. Isothermal Nucleic Acid Amplification Technology Market

Isothermal Nucleic Acid Amplification Technology Market

Isothermal Nucleic Acid Amplification Technology Market Size and Forecast (2025 - 2032), By Product Type (LAMP, SDA, HAD, NASBA, Others), By Application (Infectious Diseases, Blood Screening, Cancer, Others), By End User (Hospitals, Diagnostic Centers, Academic & Research Institutes, Others), and Geography.

Report Code: HEA00123
Report Format: PDF + PPT + Excel
Download PDF Buy Now
Report Description

Report Highlights:

From USD 1.8 billion in 2022 to USD 4.2 billion by 2032, the worldwide Isothermal Nucleic Acid Amplification Technology Market is expected to rise at a CAGR of 11.2%. Thanks to superior healthcare infrastructure and high acceptance rates of novel diagnostic technology, North America presently dominates the industry.

Particularly in view of the COVID-19 epidemic, the market is seeing notable expansion driven by growing need for fast and precise diagnostic methods. Faster results, less equipment needed, and possible point-of-care testing are just a few of the benefits offered by isothermal nucleic acid amplification technologies over conventional PCR techniques. These elements are driving the increasing uses of isothermal amplification in many sectors, including blood screening, cancer detection, and infectious illness diagnosis.



Market Dynamics:

Market Trend Increasing need for quick, point-of-care molecular diagnostics
Isothermal amplification methods are inspiring innovation in response to the trend toward distributed testing and the need for fast, reliable findings. From field hospitals to clinics, companies are creating portable, user-friendly technologies that can provide molecular diagnostic findings in many environments. Rapid testing for infectious disorders such COVID-19, influenza, and sexually transmitted infections show this tendency quite well. The capacity to execute sophisticated molecular tests outside of conventional laboratory environments is extending the reach of diagnostic capabilities and enhancing patient care in resource-limited places.

 

Driver of the Market rising frequency of cancer and infectious disorders
The isothermal nucleic acid amplification technology market is driven in great part by the growing worldwide load of cancer and infectious illnesses. These technologies provide sensitive and precise genetic markers linked with different illnesses as well as detection techniques for microorganisms. Regarding infectious illnesses, effective treatment and outbreak prevention depend on fast and precise diagnosis. Early discovery and tracking of genetic indicators may greatly enhance patient outcomes for cancer. The need for improved molecular diagnostic tools, particularly isothermal amplification techniques, keeps rising as healthcare systems all over concentrate on early diagnosis and tailored therapy. In emerging areas where the prevalence of infectious illnesses is still high and access to sophisticated diagnostic tools is increasing, this trend is especially robust.

 

Restraint of the Market Competition from more seasoned PCR techniques
Although isothermal nucleic acid amplification techniques have benefits, well-known PCR-based technologies compete with them. Because of its great sensitivity, specificity, and volume of evidence supporting its usage, PCR is still the gold standard for many molecular diagnostics uses. Many labs and medical institutes have already made investments in PCR tools and developed procedures, hence it might be difficult to change to other technologies. Furthermore time-consuming and expensive are regulatory licenses and clinical validations for novel isothermal techniques, which can hold down their acceptance in certain markets or uses. Clear benefits in terms of speed, cost-effectiveness, or simplicity of usage over conventional PCR techniques can help one overcome this limit.



Segment Overview:

Market Segment Analysis of Isothermal Nucleic Acid Amplification Technologyby Product Type: LAMP takes the stage in the market

Leading product type in the isothermal nucleic acid amplification technology market nowadays is loop-mediated isothermal amplification (LAMP). Among other benefits, LAMP provides great specificity, efficiency, and the capacity to amplify DNA under isothermal conditions usually between 60 and 65°C. This approach's simplicity, quick results, and possible application in environments with limited resources have helped it to become somewhat popular recently. LAMP has been effectively used in several diagnostic contexts, mostly for the identification of infectious diseases including COVID-19 testing. The method's excellent selectivity and effectiveness in amplifying DNA as well as its fit with basic, portable detection instruments have helped it to be widely used and dominate the market.



Regional Outlook:

Leading in market share and innovation is North America.
Currently holding the most proportion of the isothermal nucleic acid amplification technique market is North America. Early adoption of modern diagnostics technology, major expenditures in research and development, and a well-established healthcare infrastructure help to explain the region's supremacy. Particularly the United States has been leading in creating and commercializing isothermal amplification-based diagnostics technologies. Major biotechnology and pharmaceutical firms as well as several university research institutes present have encouraged creativity in this arena. Furthermore encouraging market development in the area are government projects promoting the creation of fast, point-of-care diagnostic technology and advantageous legislative frameworks. The COVID-19 epidemic underlined even more the need of speedy molecular testing, which resulted in more financing and fast-track approvals for tests based on isothermal amplification in North America.



Competitive Landscape:

Strong competition and fast technical developments define the isothermal nucleic acid amplification technology industry. To get a competitive advantage, important firms in the industry are concentrating on creating new items, broadening their product lines, and getting regulatory clearances. Commonly aiming at discovering new uses for isothermal amplification technology, collaborations between diagnostic firms and research institutes are typical. Particularly in view of the COVID-19 epidemic, which has hastened the development and use of fast molecular diagnostic technologies, the industry has witnessed an infusion of new players. While simultaneously making R&D investments to keep abreast of new technology, established firms are using their strong distribution networks and brand awareness to maintain their market positions. As the industry develops and fresh uses for isothermal amplification technologies are found, the competitive scene is projected to change even more.

 

Major Players:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Grifols, S.A.
  • Hologic, Inc.
  • Lucigen Corporation
  • QIAGEN N.V.
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Meridian Bioscience, Inc.
  • New England Biolabs
  • Eiken Chemical Co., Ltd.
Table of Content

1. INTRODUCTION

   1.1. Market Definition

   1.2. Study Scope

   1.3. Currency Conversion

   1.4. Study Period (2025- 2032)

   1.5. Regional Coverage

2. RESEARCH METHODOLOGY

   2.1. Primary Research

   2.2. Secondary Research

   2.3. Company Share Analysis

   2.4. Data Triangulation

3. EXECUTIVE SUMMARY

   3.1. Global Isothermal Nucleic Acid Amplification Technology Market (2021 – 2023)

   3.2. Global Isothermal Nucleic Acid Amplification Technology Market (2025 – 2031)

      3.2.1. Market Segment By Product Type (2025 – 2031)

      3.2.2. Market Segment By Application (2025 – 2031)

      3.2.3. Market Segment By End User (2025 – 2031)

      3.2.4. Market Segment By Region (2025 – 2031)

4. MARKET DYNAMICS

   4.1. Market Trends

      4.1.1. Growing demand for rapid, point-of-care molecular diagnostics

      4.1.2. Advancements in isothermal amplification techniques

      4.1.3. Integration with emerging technologies like microfluidics

   4.2. Market Drivers

      4.2.1. Increasing prevalence of infectious diseases and cancer

      4.2.2. Rising demand for rapid and accurate diagnostic tools

      4.2.3. Growing focus on personalized medicine

   4.3. Market Restraints

      4.3.1. Competition from established PCR technologies

      4.3.2. Limited awareness and adoption in developing regions

   4.4. Porter's Five Forces Analysis

      4.4.1. Threat of New Entrants

      4.4.2. Bargaining Power of Buyers/Consumers

      4.4.3. Bargaining Power of Suppliers

      4.4.4. Threat of Substitute Products

      4.4.5. Intensity of Competitive Rivalry

   4.5. Supply Chain Analysis

   4.6. Pricing Analysis

   4.7. Regulatory Analysis

   4.8. Pipeline Analysis

5. BY PRODUCT TYPE (MARKET VALUE (US$ MILLION) – 2025-2031*)

   5.1. LAMP

   5.2. SDA

   5.3. HAD

   5.4. NASBA

   5.5. Others

6. BY APPLICATION

   6.1. Infectious Diseases

   6.2. Blood Screening

   6.3. Cancer

   6.4. Others

7. BY END USER

   7.1. Hospitals

   7.2. Diagnostic Centers

   7.3. Academic & Research Institutes

   7.4. Others

8. GEOGRAPHY

   8.1. North America

      8.1.1. United States

      8.1.2. Canada

      8.1.3. Mexico

   8.2. South America

      8.2.1. Brazil

      8.2.2. Argentina

      8.2.3. Rest of South America

   8.3. Europe

      8.3.1. Germany

      8.3.2. United Kingdom 

      8.3.3. France

      8.3.4. Italy

      8.3.5. Spain

      8.3.6. Russia

      8.3.7. Rest of Europe

   8.4. Asia-Pacific

      8.4.1. China

      8.4.2. Japan

      8.4.3. India

      8.4.4. Australia

      8.4.5. South Korea

      8.4.6. Rest of Asia-Pacific

   8.5. Middle-East

      8.5.1. UAE

      8.5.2. Saudi Arabia

      8.5.3. Turkey

      8.5.4. Rest of Middle East

   8.6. Africa

      8.6.1. South Africa

      8.6.2. Egypt

      8.6.3. Rest of Africa

9. COMPETITVE LANDCAPE

   9.1. Key Developments

   9.2. Company Market Share Analysis

   9.3. Product Benchmarking

10. SWOT ANALYSIS

11. COMPANY PROFILES

    11.1. Abbott Laboratories

    11.2. Becton, Dickinson and Company

    11.3. bioMérieux SA

    11.4. Grifols, S.A.

    11.5. Hologic, Inc.

    11.6. Lucigen Corporation

    11.7. QIAGEN N.V.

    11.8. Quidel Corporation

    11.9. Thermo Fisher Scientific Inc.

    11.10. Meridian Bioscience, Inc.

    11.11. New England Biolabs

    11.12. Eiken Chemical Co., Ltd. (*LIST NOT EXHAUSTIVE)

12. MARKET OPPORTUNITIES

Scope of the Report

By Product Type:

  • LAMP

  • SDA

  • HAD

  • NASBA

  • Others

By Application:

  • Infectious Diseases

  • Blood Screening

  • Cancer

  • Others

By End User:

  • Hospitals

  • Diagnostic Centers

  • Academic & Research Institutes

  • Others

By Region:

  • North America

  • Europe

  • Asia-Pacific

  • Latin America

  • Middle East & Africa

Frequently Asked Questions

We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.

At aurorawaveintellects.com, we believe that every industry is important to us. Our extensive team of analysts give equal focus to various industries in order to cater to our client needs, some of them being – Healthcare & Pharma, Medical, Automotive, Electric, Chemical, Manufacturing, Energy & Power, Consumer Goods etc.
Our core expertise lies in gaining deeper insights from reliable and trusted voices in the market. We always analyse market trends over the course of multiple years and examine which topics are most relevant to our clients. We pay a great deal of attention to emerging trends, niche technologies, and the latest innovations and research to bring out the best that we can offer.
We understand that every client is different and so is their requirement. While we try to gauge our clients’ needs, we are unable to cover every possible angle of a market in an off-the-shelf report. Hence, we also provide customization options to our reports to suit your needs. If you would like to know what information we can provide about a particular topic, please get in touch with us at info@aurorawaveintellects.com.
Our Research Reports give insights into a gamut of qualitative and quantitative topics. Every Research Report contains the following: • Market landscape • Market size • Market segmentation • Market drivers, challenges, and trends • Vendor landscape For more detail on what a specific report contains, click on report details to know more. If you would like to know what information we can provide about a particular topic, please get in touch with us at info@aurorawaveintellects.com
Our Research Reports are frequently updated with new data and predictions. We also have reports from previous years for specific topics. If you need help, contact us at info@aurorawaveintellects.com and we will be happy to assist you for your query.

We at aurorawaveintellects.com offer mainly 3 types of licenses:

• Single User: Research Report copy can be distributed to a single user only

• Multi User: Research Report distribution is restricted up to 5 users.

• Corporate License :Research Report can be distributed across the company.

Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:

• PDF

• Word Document

• PPT

To purchase a research report, you can browse through various categories, industries or topics and choose a particular report. Next, choose a license type and add the report to your cart. Then simply check out and complete the payment transaction and your report will be delivered to your inbox via email..

Following modes are available for making the payment:

• Online Payment (Visa Card, Master Card, Stripe)

• Razorpay

• Net Banking

• Bank Wire Transfer

At Research Reports Inc., we believe in providing the best value and offering competitive pricing to our customers to reflect that value. However, if you would still like to find out about discounts and offers, please get in touch with us at info@aurorawaveintellects.com.
Yes, you can purchase individual sections of the report. Please get in touch with us at info@aurorawaveintellects.com with your specific request, and we will support you accordingly.
As soon as the purchase process is over and the payment transaction is complete, you will receive the receipt via email.
The purchased Research Report is delivered to your registered email address within 48 hours of receipt of payment. If in case you did not, please check your spam folder. If you still haven’t received it, please get in touch with us at info@aurorawaveintellects.com
If you would like to receive a hard copy of the report, please get in touch with us at info@aurorawaveintellects.com with details about your purchase and we will process the same.
At aurorawaveintellects.com, we offer strong after-sales support with every purchase. Feel free to call us or email us with your queries and we will ensure they are addressed appropriately.
The Research Reports we provide are designed to cater to all market participants across the value chain. However, we do understand that every report may or may not meet the exact client requirement. For any specific change or customization in the report, please get in touch with us at info@aurorawaveintellects.com with your specific request, and we will support you accordingly.

Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:

• Email: info@aurorawaveintellects.com

• United Kingdom: ++91 7382742511